27058 Investors following Dr Reddys Labs. Share this News with them.
0
Like this story, share it with millions of investors on M3
Buy Dr Reddys Labs, target of Rs 581: Angel
Angel Broking has maintained its buy rating on Dr Reddys Laboratories with a target price of Rs 581. For 3QFY2009, DRL registered a yoy growth in Net Sales of 50.5% to Rs 1,805 crore (Rs 1,199 crore).
Angel Broking has maintained its buy rating on Dr Reddys Laboratories with a target price of Rs 581 in its January 21, 2009 research report. "For 3QFY2009, DRL registered a yoy growth in Net Sales of 50.5% to Rs 1,805 crore (Rs 1,199 crore). On the valuation front, the stock is trading at 15.6x FY2009E and 13.8x FY2010E EPS. We maintain our Buy on the stock, with a target price of Rs 581," says Angel's research report.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
To read the full report click on the attachment......
|
Budget: 2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget | Budget 2012
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide | History India
| Up Polls | Latest News
| Uninor | Tata Steel | Chennai | Vodafone Essar | Mahindra Satyam | Mutual fund | Initial public offering | MCX | BSE Sensex | India 
